SEC Form 4 · accession 0001209191-15-087453
Bone Biologics Corp · BBLG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
B Chia Soo
Director
Period of report
Dec 28, 2015
Accepted (ET)
Dec 31, 2015 · 10:42 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001419554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 28, 2015 | A | 9,176 | $0.00 | A | 2,988,078 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $1.59 | Dec 28, 2015 | A | 68,553 | A | — | Dec 27, 2025 | Common Stock | 68,553 | 68,553 | D |
Explanation of responses
- F1These shares were acquired by the Reporting Person pursuant to Reporting Person's non-employee director offer letter with the Issuer.
- F2Immediately exercisable.